Drug Profile
VAS 047
Alternative Names: VAS-047Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Vastrata
- Class Analgesics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Headache
Highest Development Phases
- No development reported Headache
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Headache in United Kingdom
- 20 Jul 2016 VAS 047 is available for licensing as of 20 Jul 2016. http://vastrata.com/
- 20 Jul 2016 Preclinical trials in Headache in United Kingdom (unspecified route)